IMTX

Immatics N.V.

Healthcare · Biotechnology

$267.87 sample

+2.01 (+0.76%) 1D

Market cap

$1.18T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-25

Alerts

8

Price$267.87 +10.27% 3M daily closessample

267.87238.73

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider sell: Chief Financial Officer
Oct 05INSInsider sell: Director
Sep 25SECDEF 14A filed
Sep 22INSInsider sell: Chief Financial Officer
Sep 16SECForm 144 filed
Sep 08INSInsider sell: EVP, Operations
Sep 02INSInsider sell: Director
Aug 26INSInsider sell: Director

Sign up to see the real IMTX record →

Company facts

SEC EDGAR registration

Name: Immatics N.V.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +60sample, -100 to +100
Reporting currency: USD

Who is positioning in IMTX

sample

Insiders: 27 insider transactions over 90 days, net selling, $661.1M
Congress: 3 members traded over 90 days
Institutions · 13F: 34 funds hold $12.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$69.9B +20.8% y/y

Q4 2024Q3 2026

Inventory$41.9B +21.8% y/y

Q4 2024Q3 2026

Accounts receivable$30.1B +11.1% y/y

Q4 2024Q3 2026

Total debt$84.0B +19.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $325.5B +6.2% 3M
Sample peer B: $485.6B -2.0% 3M
Sample peer C: $1.08T -3.8% 3M
Sample peer D: $930.8B -3.7% 3M
Sample peer E: $206.6B -8.2% 3M